Delivery Order SPE2DR25D2108-SPE2DR26F6QQ7
- Not listed
- The Defense Logistics Agency awarded a $16,631.46 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $21,654.75 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed price delivery order is set to be completed by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $17,587.91 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal contract portfolio and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,138.41. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, is issued without a set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $16,927.84 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $1,988.27. This firm fixed-price delivery order is due for completion by November 6, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition without set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,456.77 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a purchase from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6QQ7Delivery Order
The Defense Logistics Agency awarded a $16,728.21 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 5, 2025, with performance fulfillment from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle supplying military healthcare systems worldwide with brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement, particularly supporting Defense Health Agency operations and other government healthcare systems. The Eliquis order supports DLA's broader mission to ensure pharmaceutical supply chain continuity for military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 11/4/25 |